Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
B. Berger, G. Stenström, G. Sundkvist. (2000) Random C-peptide in the classification of diabetes. Scandinavian Journal of Clinical and Laboratory Investigation 60:8, pages 687-693.
Read now
Read now
H. J. Gjessing, E. M. Damsgaard, L. E. Matzen, O. K. Faber & A. Frøland. (1988) The beta-cell response to glucagon and mixed meal stimulation in non-insulin dependent diabetes. Scandinavian Journal of Clinical and Laboratory Investigation 48:8, pages 771-777.
Read now
Read now
J. Malmquist & G. Birgerstam. (1986) Assays of pancreatic B cell secretory products: Utility in investigative and clinical diabetology. Scandinavian Journal of Clinical and Laboratory Investigation 46:8, pages 705-713.
Read now
Read now
Pertti Koskinen, Jorma Viikari, Kerttu Irjala, Hanna-Leena Kaihola & Pentti Seppälä. (1986) Plasma and urinary C-peptide in the classification of adult diabetics. Scandinavian Journal of Clinical and Laboratory Investigation 46:7, pages 655-663.
Read now
Read now
Articles from other publishers (21)
Abhishek Prakash Gupta, Partha Pratim Chakraborty, Ratan Halder, Arghyadip Sahoo & Krishnendu Roy. (2021) Post-usual meal C-peptide as a reliable and practical alternative to C-peptide following glucagon or standardized mixed-meal for β-cell reserve: a comparative study between three stimulatory methods in different types of diabetes. International Journal of Diabetes in Developing Countries 42:4, pages 657-665.
Crossref
Crossref
Wei-Chih Chou, Yen-Yin Chou, Yu-Wen Pan & Meng-Che Tsai. (2021) Is Non-Stimulated C-Peptide at Diagnosis a Good Predictive Value for Insulin Use at Two Years after Diagnosis in Pediatric Diabetic Patients?. Medicina 57:9, pages 902.
Crossref
Crossref
Minoru Iwata, Yumi Matsushita, Kazuhito Fukuda, Tatsurou Wakura, Keisuke Okabe, Yukiko Koshimizu, Yasuo Fukushima, Chikaaki Kobashi, Yu Yamazaki, Hisae Honoki, Hikari Suzuki, Mika Kigawa & Kazuyuki Tobe. (2014) Secretory units of islets in transplantation index is a useful predictor of insulin requirement in Japanese type 2 diabetic patients. Journal of Diabetes Investigation 5:5, pages 570-580.
Crossref
Crossref
A. G. Jones & A. T. Hattersley. (2013) The clinical utility of C‐peptide measurement in the care of patients with diabetes. Diabetic Medicine 30:7, pages 803-817.
Crossref
Crossref
Shogo Funakoshi, Shimpei Fujimoto, Akihiro Hamasaki, Hideya Fujiwara, Yoshihito Fujita, Kaori Ikeda, Shiho Takahara, Kazuaki Nagashima, Masaya Hosokawa, Yutaka Seino & Nobuya Inagaki. (2011) Utility of indices using C-peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetes. Journal of Diabetes Investigation 2:4, pages 297-303.
Crossref
Crossref
Bo-Yeon KimChan-Hee JungJi-Oh MokChul-Hee Kim. (2011) Factors Associated with Long-Term Oral Hypoglycemic Agent Responsiveness in Korean Patients with Type 2 Diabetes Mellitus. Diabetes & Metabolism Journal 35:3, pages 282.
Crossref
Crossref
Atsushi GOTO, Maki TAKAICHI, Miyako KISHIMOTO, Yoshihiko TAKAHASHI, Hiroshi KAJIO, Takuro SHIMBO & Mitsuhik NODA. (2010) Body Mass Index, Fasting Plasma Glucose Levels, and C-peptide Levels as Predictors of the Future Insulin Use in Japanese Type 2 Diabetic Patients. Endocrine Journal 57:3, pages 237-244.
Crossref
Crossref
Yi-Ching Tung, Jing-Sheng Lee, Wen-Yu Tsai & Pei-Hung Hsiao. (2007) Evaluation of β-cell function in diabetic Taiwanese children using a 6-min glucagon test. European Journal of Pediatrics 167:7, pages 801-805.
Crossref
Crossref
María A. Ramos-Román, Antonio Piñero-Piloña, Beverley Adams-Huet & Philip Raskin. (2006) Comparison of type 1, type 2, and atypical ketosis-prone diabetes at 4 years of diabetes duration. Journal of Diabetes and its Complications 20:3, pages 137-144.
Crossref
Crossref
M. R. Maldonado, M. E. Otiniano, F. Cheema, L. Rodriguez & A. Balasubramanyam. (2005) Factors associated with insulin discontinuation in subjects with ketosis-prone diabetes but preserved beta-cell function. Diabetic Medicine 22:12, pages 1744-1750.
Crossref
Crossref
Max E. Otiniano, Ashok Balasubramanyam & Mario Maldonado. (2005) Presence of the metabolic syndrome distinguishes patients with ketosis-prone diabetes who have a Type 2 diabetic phenotype. Journal of Diabetes and its Complications 19:6, pages 313-318.
Crossref
Crossref
M. Albareda, M. Rigla, J. Rodríguez-Espinosa, A. Caballero, A. Chico, R. Cabezas, G. Carreras & A. Pérez. (2005) Influence of exogenous insulin on C-peptide levels in subjects with type 2 diabetes. Diabetes Research and Clinical Practice 68:3, pages 202-206.
Crossref
Crossref
Mario Maldonado, Christiane S. Hampe, Lakshmi K. Gaur, Susana D’Amico, Dinakar Iyer, Lisa P. Hammerle, Douglas Bolgiano, Lucille Rodriguez, Arun Rajan, Åke Lernmark & Ashok Balasubramanyam. (2003) Ketosis-Prone Diabetes: Dissection of a Heterogeneous Syndrome Using an Immunogenetic and β-Cell Functional Classification, Prospective Analysis, and Clinical Outcomes. The Journal of Clinical Endocrinology & Metabolism 88:11, pages 5090-5098.
Crossref
Crossref
Jürgen Schrezenmeir, Kay Dirting & Peter Papazov. (2002) Controlled multicenter study on the effect of computer assistance in intensive insulin therapy of type 1 diabetics. Computer Methods and Programs in Biomedicine 69:2, pages 97-114.
Crossref
Crossref
Henry S. Kahn, Virginia G. Dunbar, David C. Ziemer & Lawrence S. Phillips. (2012) Diabetes in Urban African Americans. XII. Anthropometry for Assessing Municipal Hospital Outpatients Recently Diagnosed with Type 2 Diabetes. Obesity Research 6:3, pages 238-245.
Crossref
Crossref
Micheline C. Deschênes, Stuart G. Coupland, Stuart A. Ross & Gordon H. Fick. (1997) Early macular dysfunction detected by focal electroretinographic recording in non-insulin-dependent diabetics without retinopathy. Documenta Ophthalmologica 94:3, pages 223-237.
Crossref
Crossref
P. Di Bonito, A. De Bellis, B. Capaldo, S. Turco, G. Corigliano, E. Pace & A. Bizzarro. (1996) Soluble CD8 antigen, stimulated C-peptide and islet cell antibodies are predictors of insulin requirement in newly diagnosed patients with unclassifiable diabetes. Acta Diabetologica 33:3, pages 220-224.
Crossref
Crossref
Mary Jane Prior, Thaddeus Prout, Dayton Miller, Robin Ewart & Dinesh Kumar. (1993) C-peptide and the classification of diabetes mellitus patients in the Early treatment diabetic retinopathy study report number 6. Annals of Epidemiology 3:1, pages 9-17.
Crossref
Crossref
L. Scionti, P. Misericordia, A. Santucci, F. Santeusanio & P. Brunetti. (1992) A simple clinical approach to discriminate between ?true? and ?pseudo? secondary failure to oral hypoglycaemic agents. Acta Diabetologica 29:1, pages 20-24.
Crossref
Crossref
B.H.R. Wolffenbuttel, R.F.A. Weber, P.M. van Koetsveld, L. Weeks & L. Verschoor. (2009) A Randomized Crossover Study of Sulphonylurea and Insulin Treatment in Patients with Type 2 Diabetes Poorly Controlled on Dietary Therapy. Diabetic Medicine 6:6, pages 520-525.
Crossref
Crossref
H. J. Gjessing, L. E. Matzen, P. C. Pedersen, O. K. Faber & A. Frøland. (2009) Insulin Requirement in Non‐insulin‐dependent Diabetes Mellitus: Relation to Simple Tests of Islet B‐cell Function and Insulin Sensitivity. Diabetic Medicine 5:4, pages 328-332.
Crossref
Crossref